Login

Global-Dining, Inc. featured an episode with an executive chef and restaurant owner discussing culinary insights, alongside a mention of Apple CEO Tim Cook. 00:10:00

Share On Facebook Share On Twitter

Kozo Hasegawa. CEO at Global-Dining, Inc

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Key Topics We Address in Our Financial Planning Meetings | Raquel Hinman - Founder & Principal of Hinman Financial Planning, Inc.
00:00:00
Commercializing products in the musculoskeletal segment of the marketplace - Adam Gridley, President and CEO, Histogenics Corp
00:10:00
Claudio Erba, CEO, and Alessio Artuffo, CRO of Docebo Inc., provide insights in "The View From The C-Suite," juxtaposed with Warren Buffett's endorsement of Greg Abel for Berkshire Hathaway.|Claudio is the founder and CEO of Docebo
00:10:00
Modify IT Holdings' strategy of acquiring growth | TIFFANY DUNSDON, Chief Executive Officer, Adapt IT Holdings Ltd ADI:JNB
01:10:00
CEO Insights on Government Tenants and Portfolio Strategy | Roger Waesche Jr., CEO, Corporate Office Properties Trust.
00:10:00
SolGold: Ecuadorian Copper Exploration and Development
00:10:00
Do you WANT Venture Capital|Andrew Goldner, Co-Founder, GrowthX
00:00:00
Redx Pharma presents at European Society for Medical Oncology (ESMO) Congress - Lisa Anson Chief Executive Officer, Redx Pharma
00:10:00
Exploring Private Credit Opportunities: Insights from Drew McKnight of Fortress on Off The Tape with Dan, Guy, and Kaitlin Malin
00:10:00
Insights from Oaktree’s 35-Year Investment Philosophy | Howard Marks - Co-founder & Co-chairman, Oaktree Capital Management
00:10:00
RS Minerals Announces Key Soil Results and New License Acquisition in Kazakhstan
00:10:00
Discovering and developing products for patients with cancer|Dr. Steven Fruchtman,Ceo,Onconova Therapeutics Inc

© 2017 - Neuhu+